Retrieved from Medications containing semaglutide marketed for type 2 diabetes or weight loss
h , Bar graph summarizing the effect of NMDA-induced inward current after control (aCSF, n = 5 neurons), GLP-1 (50 M, n = 5 neurons), MK-801 (50 M, n = 5 neurons) or GLP-1MK-801 (50 M, n = 5 neurons)
Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons
Nutritional priorities to support GLP 1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
In microglial BV2 cells semaglutide dose-dependently inhibited apoptosis induced by -amyloid (1-42) and promoted the transformation of microglia from M1 to M2, thereby exerting anti-inflammatory and neuroprotective effects [50]